You are required to be logged in to access the full website
Click here if you have forgotten your username or password
5 October 2026 - Global biotechnology company Alvotech (NASDAQ: ALVO; STO: ALVO-SDB), which develops and manufactures biosimilar medicines, said on Monday it has received US Food and Drug Administration approval for a supplement to the Biologics Lice...
Ractigen Therapeutics reports positive first-in-human data for RAG-18 in Duchenne muscular dystrophy
5 October 2026 - Ractigen Therapeutics, a China-based, clinical-stage biotechnology company, announced on Saturday the presentation of positive first-in-human clinical data from its ongoing Phase I trial of RAG-18 during a Late-Breaking Oral Presenta...
5 October 2026 - Australian biopharma company CSL Limited (ASX:CSL) (USOTC:CSLLY) and Swiss biotechnology company Alentis Therapeutics announced on Sunday that they have entered into an exclusive global collaboration agreement to co-develop and co-pr...
5 October 2026 - AnnJi Pharmaceutical Co Ltd (TPEx:7754), a Taiwan-based, clinical-stage drug development company focused on innovative small molecules, announced on Monday that it is proceeding with the US arm of its pivotal Phase 3 ROMA-KD trial of...
5 October 2026 - Aroa Biosurgery Limited (ASX:ARX), a New Zealand-based soft tissue regeneration company, on Monday reported positive results from a prospective, multicentre randomised controlled trial (RCT) of Symphony, published in the Internationa...
M2 Pharma brings you breaking news and information on the
global pharmaceuticals industry, helping you to stay one step ahead of the competition.
Click here to subscribe
Click here to subscribe